Is Anyone Participating In The UC Davis Clinical Trial For Follicular Lymphoma (obinutuzumabt/ibrutinab/venetoclax)? | MyLymphomaTeam

Connect with others who understand.

sign up Log in
Resources
About MyLymphomaTeam
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
Is Anyone Participating In The UC Davis Clinical Trial For Follicular Lymphoma (obinutuzumabt/ibrutinab/venetoclax)?
A MyLymphomaTeam Member asked a question 💭
posted April 14
•
Be the first to like/hug
A MyLymphomaTeam Member

Good luck

posted April 16
A MyLymphomaTeam Member

Thanks Frank, I am going to go this route if I’m allowed into the trial. I’ll know this Friday. Hopeful.

posted April 15
A MyLymphomaTeam Member

Obinutuzumabt is a monoclonal antibody to aCD20 marker president on lymphoma cell s.Similar to rituxin but said to be more effective and less toxic

Venetolax attacks bcl2 antigen on the surface of lymphoma cells and allows the to self destruct
Very cutting edge effective treatment good oncologist

posted April 15

Related content

View All
Has Anyone Ever Been Diagnosed With Two Different Types Of Lymphoma?
A MyLymphomaTeam Member asked a question 💭
I Have Follicular Lymphoma. I'm Trying To Find Out If Anybody Has Had Antibodies. I Can't Take Any More Of The Adromycin.
A MyLymphomaTeam Member asked a question 💭
I've Been Offered A Clinical Trial By My Oncologist At Cleveland Clinic. Anyone Have Input As To Clinical Trials? Pros..cons?
A MyLymphomaTeam Member asked a question 💭
Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in